צ'רקודוט סוספנסיה מימית 200 מ"ג/מ"ל
genmedix - activated charcoal 0.2 g/ml - suspension - charcoal preparations - emergency antidote in treatment of poisoning by most drugs and chemicals.
אימונאט 250 iu
teva medical marketing ltd. - factor viii human coagulation 250 iu/vial - powder for solution for injection - coagulation factor viii - treatment and prophylaxis of bleeding in patients with congenital (haemophilia a) or acquired factor viii deficiency. von willebrand's disease with factor viii deficiency.
אימונאט 500 iu
teva medical marketing ltd. - factor viii human coagulation vhsd treated 500 iu/vial - powder for solution for injection - coagulation factor viii - treatment and prophylaxis of bleeding in patients with congenital (haemophilia a) or acquired factor viii deficiency. von willebrand's disease with factor viii deficiency.
אימונאט 1000 iu
teva medical marketing ltd. - factor viii human coagulation 1000 iu/vial - powder for solution for injection - coagulation factor viii - treatment and prophylaxis of bleeding in patients with congenital (haemophilia a) or acquired factor viii deficiency. von willebrand's disease with factor viii deficiency.
ביקאלוטמיד אינובמד 150 מג
inovamed ltd - bicalutamide - טבליות מצופות פילם - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0), bicalutamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable
ארומזין
pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.
thermage thermacool system
"a.m.i. technologies, ltd." - רופא - טיפול קוסמטי ע'י גלי רדיו
"allon 2001, criticool, garments & accessories"
m.t.r.e advanced technologies ltd. - אחות
allon 2001, criticool, garments & accessories
m.t.r.e advanced technologies ltd. - אחות
biopince-biopsy gun&coaxial introducer n
nim ltd. - רופא - אקדח לביופסיה לרקמות רכות ומחטי מעבר לביופסיה